File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Cost-effectiveness of subthalmic nucleus deep brain stimulation for the treatment of advanced Parkinson disease in Hong Kong: A prospective study

TitleCost-effectiveness of subthalmic nucleus deep brain stimulation for the treatment of advanced Parkinson disease in Hong Kong: A prospective study
Authors
Zhu, X. L.Chan, Danny T.M.Lau, Claire K.Y.Poon, Wai S.Mok, Vincent C.T.Chan, Anne Y.Y.Wong, Lawrence K.S.Yeung, Jonas H.M.Leung, Michael C.M.Tang, Venus Y.H.Wong, Rosanna K.M.Yeung, Carol
KeywordsCost-effectiveness
Deep brain stimulation
EQ5D
Parkinson disease
PD39
QALY
Quality of Life
Subthalamic nucleus
UPDRS
Issue Date2014
Citation
World Neurosurgery, 2014, v. 82, n. 6, p. 987-993 How to Cite?
DOI: http://dx.doi.org/10.1016/j.wneu.2014.08.051
AbstractBackground Deep brain stimulation (DBS) is an effective but costly treatment for patients with advanced Parkinson disease (PD). This study examined the cost-effectiveness of DBS in relation to its improved effectiveness to help funding decision makers decide whether the treatment should be adopted. The incremental cost-effective ratio (ICER) per quality-adjusted life year has been benchmarked as being between US$50,000 and US$100,000 by US agencies, whereas it is less than €30,000 per quality-adjusted life year in Europe.
Persistent Identifierhttp://hdl.handle.net/10722/325283
ISSN
1878-8750
2023 Impact Factor: 1.9
2023 SCImago Journal Rankings: 0.654
ISI Accession Number ID
WOS:000347635900058

 

DC FieldValueLanguage
dc.contributor.authorZhu, X. L.-
dc.contributor.authorChan, Danny T.M.-
dc.contributor.authorLau, Claire K.Y.-
dc.contributor.authorPoon, Wai S.-
dc.contributor.authorMok, Vincent C.T.-
dc.contributor.authorChan, Anne Y.Y.-
dc.contributor.authorWong, Lawrence K.S.-
dc.contributor.authorYeung, Jonas H.M.-
dc.contributor.authorLeung, Michael C.M.-
dc.contributor.authorTang, Venus Y.H.-
dc.contributor.authorWong, Rosanna K.M.-
dc.contributor.authorYeung, Carol-
dc.date.accessioned2023-02-27T07:31:13Z-
dc.date.available2023-02-27T07:31:13Z-
dc.date.issued2014-
dc.identifier.citationWorld Neurosurgery, 2014, v. 82, n. 6, p. 987-993-
dc.identifier.issn1878-8750-
dc.identifier.urihttp://hdl.handle.net/10722/325283-
dc.description.abstractBackground Deep brain stimulation (DBS) is an effective but costly treatment for patients with advanced Parkinson disease (PD). This study examined the cost-effectiveness of DBS in relation to its improved effectiveness to help funding decision makers decide whether the treatment should be adopted. The incremental cost-effective ratio (ICER) per quality-adjusted life year has been benchmarked as being between US$50,000 and US$100,000 by US agencies, whereas it is less than €30,000 per quality-adjusted life year in Europe.-
dc.languageeng-
dc.relation.ispartofWorld Neurosurgery-
dc.subjectCost-effectiveness-
dc.subjectDeep brain stimulation-
dc.subjectEQ5D-
dc.subjectParkinson disease-
dc.subjectPD39-
dc.subjectQALY-
dc.subjectQuality of Life-
dc.subjectSubthalamic nucleus-
dc.subjectUPDRS-
dc.titleCost-effectiveness of subthalmic nucleus deep brain stimulation for the treatment of advanced Parkinson disease in Hong Kong: A prospective study-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.wneu.2014.08.051-
dc.identifier.pmid25175275-
dc.identifier.scopuseid_2-s2.0-84916930342-
dc.identifier.volume82-
dc.identifier.issue6-
dc.identifier.spage987-
dc.identifier.epage993-
dc.identifier.eissn1878-8769-
dc.identifier.isiWOS:000347635900058-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats